Mai Nguyen-Huynh to Aromatase Inhibitors
This is a "connection" page, showing publications Mai Nguyen-Huynh has written about Aromatase Inhibitors.
Connection Strength
0.056
-
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Res Treat. 2023 Aug; 201(1):117-126.
Score: 0.056